Cargando…

Novel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte growth factor be beneficial?

Detalles Bibliográficos
Autores principales:	Guo, Ying-Hua, Su, Long-Xiang, Guo, Na, Liu, Chang-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2012
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418913/ https://www.ncbi.nlm.nih.gov/pubmed/22916069 http://dx.doi.org/10.3724/SP.J.1263.2012.02131

Ejemplares similares

15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
por: Ahn, Kyung Jin, et al.
Publicado: (2019)

Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension
por: Kalemci, Serdar, et al.
Publicado: (2019)

Clinical response to calcium channel blockers in a hemodynamically unstable patient with reactive idiopathic pulmonary arterial hypertension
por: Kopec, Grzegorz, et al.
Publicado: (2017)

Overdue to understand anticoagulation in pulmonary arterial hypertension
por: Parikh, Kishan S., et al.
Publicado: (2018)

Pulmonary arterial hypertension incidence in Latvia in 2019
por: Kaulins, Ricards, et al.
Publicado: (2022)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Hoarseness of voice as presenting complaint of idiopathic pulmonary arterial hypertension
por: Garg, Rajiv, et al.
Publicado: (2017)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

Revisiting epidural anaesthesia in a parturient with idiopathic pulmonary hypertension posted for caesarean section
por: Manohar, Manas Vithal, et al.
Publicado: (2014)

Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient
por: Raamsteeboers, Aniek J., et al.
Publicado: (2014)

Inhaled iloprost as third add-on therapy in idiopathic pulmonary arterial hypertension
por: Fernandes, Caio J.C.S., et al.
Publicado: (2021)

Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016)

When to Image in Idiopathic Intracranial Hypertension
por: Rajasekhar, Arockia, et al.
Publicado: (2016)

Obesity, Ethnicity and Idiopathic Intracranial Hypertension
por: Gafoor, V. Abdul, et al.
Publicado: (2019)

Estrogen metabolites in a small cohort of patients with idiopathic pulmonary arterial hypertension
por: Denver, Nina, et al.
Publicado: (2020)

Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection
por: Sahay, Sandeep, et al.
Publicado: (2020)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Preoperative pulmonary artery hypertension as a risk factor: the tip of the iceberg
por: Engin, Mesut, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Pattern of Idiopathic Intracranial Hypertension in Indian Population
por: Pal, Asutosh, et al.
Publicado: (2019)

Optical Coherence Tomography in Idiopathic Intracranial Hypertension
por: Venugopal, N.
Publicado: (2022)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

Are statins beneficial for the treatment of pulmonary hypertension?
por: Wang, Lei, et al.
Publicado: (2017)

Sustained response to low-dose nifedipine in a patient with idiopathic pulmonary arterial hypertension
por: Nasser, Mouhamad, et al.
Publicado: (2018)

Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
por: Chebib, Nader, et al.
Publicado: (2017)

Sex-specific cardiopulmonary exercise testing indices related to hemodynamics in idiopathic pulmonary arterial hypertension
por: Yuan, Ping, et al.
Publicado: (2017)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Pulmonary paracoccidioidomycosis‐induced pulmonary hypertension
por: Batah, Sabrina Setembre, et al.
Publicado: (2020)

Monitoring Pulmonary Thrombectomy: What Information Can Be Gained with Arterial Spin Labeling MRI?
por: Zhang, Cecilia, et al.
Publicado: (2022)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Hepatocyte growth factor concentration during the first day of acute coronary syndrome
por: Konopka, Anna, et al.
Publicado: (2012)

Rapid visual loss associated with fulminant idiopathic intracranial hypertension
por: Saraswat, Neeraj, et al.
Publicado: (2019)

Multicolor Imaging Characteristics of Peripapillary Wrinkles in Idiopathic Intracranial Hypertension
por: Priya, Sweksha, et al.
Publicado: (2022)

Interpretation of a new biomarker for the right ventricle introduced to evaluate the severity of pulmonary arterial hypertension
por: Kerkhof, Peter L.M., et al.
Publicado: (2019)

Ameliorated nailfold capillary morphology of patients with pulmonary arterial hypertension in systemic sclerosis, treated with riociguat
por: Sugimoto, Tomohiro, et al.
Publicado: (2023)

Understanding the perspective of patients with pulmonary arterial hypertension: looking beyond health-related quality of life
por: Aguirre-Camacho, Aldo
Publicado: (2021)

Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension
por: Frech, Tracy M., et al.
Publicado: (2022)

Pulmonary artery hypertension in mitral stenosis: Role of right ventricular stroke volume, atrio-ventricular compliance, and pulmonary venous compliance
por: Neema, Praveen Kumar, et al.
Publicado: (2012)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dghb6s9o1ms1cndsfu7nghk3d8